BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/27/2025 8:08:12 AM | Browse: 18 | Download: 54
 |
Received |
|
2025-07-14 03:07 |
|
Peer-Review Started |
|
2025-07-14 03:07 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-07-18 08:04 |
|
Revised |
|
2025-07-29 16:12 |
|
Second Decision |
|
2025-09-16 02:35 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-09-16 03:27 |
|
Articles in Press |
|
2025-09-16 03:27 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-10-21 01:51 |
|
Publish the Manuscript Online |
|
2025-10-27 08:08 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Prognostic role of histone deacetylase 10 in colorectal cancer: Strengths and gaps
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ali Afzal, Chatchai Muanprasat and Muhammad Babar Khawar |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Chatchai Muanprasat, Professor, Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, 270 Rama VI Road/Phutthamonthon 4 Road, Bangpla 10540, Bangplee, Thailand. chatchai.mua@mahidol.ac.th |
| Key Words |
Histone deacetylase 10; Colorectal cancer; Tumor microenvironment; Immunotherapy resistance; P53-programmed death ligand 1 axis |
| Core Tip |
Histone deacetylase 10 (HDAC10) plays a multifaceted role in colorectal cancer by modulating immune evasion, chemoresistance, and transcriptional regulation. Its suppression influences CD8⁺ T cell activation, enhances p53 expression, and reduces programmed death ligand 1 levels, suggesting critical involvement in tumor-immune interactions. Selective HDAC10 inhibition, unlike pan-HDAC blockade, may offer targeted therapeutic benefit, particularly in microsatellite-stable tumors. Further in vivo studies and mechanistic dissection of HDAC10-p53-programmed death ligand 1 signaling are essential to harness its full potential in reshaping the tumor microenvironment and improving immunotherapy outcomes. |
| Publish Date |
2025-10-27 08:08 |
| Citation |
<p>Afzal A, Muanprasat C, Khawar MB. Prognostic role of histone deacetylase 10 in colorectal cancer: Strengths and gaps. <i>World J Gastroenterol</i> 2025; 31(40): 111951</p> |
| URL |
https://www.wjgnet.com/1007-9327/full/v31/i40/111951.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v31.i40.111951 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
